Searched for
JB PHARMA Q2 RESULTS
Central Drugs Laboratories find 46 drug samples not of standard quality for MayHealth officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratorie...- Tata Capital shares slip 3% after stock rallies 17% in one week to lifetime high. What’s ahead?Tata Capital shares saw a dip on Monday following a significant rally that propelled them to an all-time high last week. Despite a recent s...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Health insurance: Overall claims experience needs improvement in India; delays, rejections are big pain points in reimbursement, says surveyPolicybazaar's latest Health Claims Experience Index reveals that while cashless claims are preferred, the overall process needs significan...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- ICICI Prudential AMC shares fall 2% as IPO lock-in expiry frees up Rs 1.2 lakh crore stake for tradeICICI Prudential AMC shares dropped 2% to Rs 513 as 34.4 crore shares became eligible for trade post IPO lock-in expiry. The company's stoc...
- TCS, Infosys, Wipro, other IT stocks crash up to 8% as Accenture lowers FY26 guidanceIndian IT stocks, including TCS and Infosys, tumbled up to 8% after Accenture lowered its annual revenue growth forecast, signaling continu...
- ITR-3 release date: Who should file this income tax return form as I-T Department enables online filing, Excel utilities for itThe Income Tax Department has launched online filing and Excel utility for Income Tax Return-3 for Assessment Year 2026-27. This form is fo...
- Buy, Sell or Hold: Morgan Stanley raises target price on NYKAA; Elara Capital maintains buy on Devyani InternationalBrokerage views on Indian equities are mixed as Morgan Stanley raises Nykaa's target price on ambitious FY30 growth plans. Conversely, conc...
- HDFC Bank shares in focus as RBI approves 3-month extension for Keki Mistry as interim chairmanHDFC Bank's interim chairman, Keki Mistry, has received a three-month extension from the RBI until September 18, 2026, easing concerns abou...
- Tay Keith cause of death: What happened to hip-hop producer? All about Brytavious Lakeith Chamber who passes away at the age of 29, watch his last live for audienceTay Keith cause of death: Tay Keith received Bachelor’s degree in Mass Communication, with a concentration in media management at Middle Te...
- Accenture net income rises to $2.39 billion during March-May quarterAccenture announced strong financial results for its March-May quarter. The IT services giant posted a net income of USD 2.39 billion, an i...
- AP Intermediate Supplementary Results 2026 out at resultsbie. ap. gov. in, BIEAP 1st, 2nd year results at bie. ap. gov. inresultsbie. ap. gov. in AP Inter Supply Results 2026 Released: The Board of Intermediate Education, Andhra Pradesh has released the AP Inte...
- Mobikwik shares in focus as IPO lock-in expiry frees up stake worth Rs 317 crore for tradeThe shares of the fintech platform had made a solid market debut in December, 2024, listing with nearly 59% premium over the IPO price at R...
- Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...
- Dividend alert! Last date to buy Tata Tech, HDB Financial, 6 other stocks for dividends worth Rs 36The shares of Tata Technologies on Thursday will turn ex-record date for a special dividend of Rs 3.35 per share and a final dividend of Rs...
- Bonus bonanza! Last date to buy Brigade Enterprises shares for 1:3 bonus issue rewardBrigade Enterprises in May announced its first bonus issue in around seven years, along with the release of its Q4 results. It said its boa...
- Two Trades for Today: 2 pharma companies – a large-cap for a 5% rise, and a mid-cap stock for a gain of 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Market Trading Guide: Allied Blenders among 2 stock recommendations for FridayDomestic markets recovered modestly on easing oil prices and selective buying in banking and pharma stocks. Analysts have recommended Allie...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
Load More
